The latest news from Verily
Wednesday, April 19, 2017
The field of medicine is ever-evolving, and the hope is that recent advances in technology will continue to spur the next generation of medical discoveries. At Verily, we have been focused on creating new tools to collect and organize information in ways previously not possible so that we can make the information useful. These initiatives, we believe, may chart a course towards the ultimate goal of improving human health. Our aim with Project Baseline is to contribute meaningfully to these efforts and to scientific research more broadly.
The Project Baseline study will collect a comprehensive set of health information both within and outside the four walls of a clinic. Within the clinic, a broad group of participants - including those who are exceptionally healthy, at-risk of disease, and with overt disease - will be providing deep data on a diverse set of measurements with repeat sampling over the course of four years. To bridge these encounters, we have also developed tools such as the investigational
and the Baseline mobile app to allow participants to provide more continuous insights throughout their everyday lives.
That means the Project Baseline study dataset will include clinical, molecular, imaging, self-reported, behavioral, environmental, sensor and other health-related measurements. To organize this information, we are creating an infrastructure that can process multi-dimensional health data – much of which have never been combined for an individual. Our vision is that this data platform can serve as a single query source and may be used for more seamless data integration and collaboration.
We recognize that we cannot achieve this vision in a silo. Teams across Verily have united around the Project Baseline study, and we work closely with Duke University School of Medicine and Stanford Medicine, as well as other partners from academia, medicine, science, patient-advocacy, engineering and design. In the future, the intent is to make de-identified data from the Project Baseline study available to qualified researchers to spur new ideas across the broad ecosystem. Importantly, the participants are at the center of this study. They will serve as active collaborators alongside the rest of the Project Baseline study team and have the option to receive certain health data and test results to share with a doctor.
The Project Baseline study is therefore a united effort to map human health. To achieve this goal, we are creating a new set of tools for medical discovery, with the aspiration that these tools and others from the broader community will pave the way for rich real-world insights, and potentially one day add to the way care is delivered. Today, we begin.
For more information, visit
Posted by Jessica Mega, MD, MPH, Chief Medical Officer at Verily
Introducing Verily Study Watch
Friday, April 14, 2017
Today, we are proud to debut our newest investigational device, the Verily Study Watch. The ability to passively capture health data is critical to the success of continuous care platforms and clinical research. Study Watch represents another step in our targeted efforts to create new tools for unobtrusive biosensing. While numerous wearables exist in the market, we have a specific need outside of these offerings: namely, the scalable collection of rich and complex datasets across clinical and observational studies.
Note: Study Watch is an investigational device and is not available for sale.
The architecture of Study Watch was tailored specifically for high quality signals and seamless usage, with consideration of the needs of observational studies, such as how continuous wear impacts a user’s experience. These design and functionality decisions were reinforced by feedback from users, researchers, and clinicians.
Verily Study Watch is designed with these key features:
Multiple physiological and environmental sensors are designed to measure relevant signals for studies spanning cardiovascular, movement disorders, and other areas. Examples include electrocardiogram (ECG), heart rate, electrodermal activity, and inertial movements.
A long battery life of up to one week in order to drive better user compliance during longitudinal studies.
Large internal storage and data compression allow the device to store weeks’ worth of raw data, thus relaxing the need to frequently sync the device.
A powerful processor supports real time algorithms on the device.
The firmware is designed to be robust for future extensions, such as over-the-air updates, new algorithms, and user interface upgrades.
The display is always on so that time is always shown. The display is low power and high resolution for an appealing look and a robust user interface. Note: currently, only time and certain instructions are displayed. No other information is provided back to the user.
Because the investigational device stores health data, all data are encrypted on the device for security. The encrypted data are uploaded and processed in the cloud using Verily’s backend algorithms and machine learning tools. This infrastructure is highly scalable and can serve population studies consisting of large volumes of data.
Study Watch will be used in several observational studies conducted by Verily’s partners, including the
Personalized Parkinson’s Project
, a multi-year study to identify patterns in the progression of Parkinson’s disease and provide a foundation for more personalized treatments. Also, Study Watch will be used in the forthcoming
, a longitudinal study exploring transitions between health and disease. In the future, we plan to incorporate Study Watch in a broad array of health applications.
Posted by David He, Technical Lead; Tushar Parlikar, Product Manager; and Harry Xiao, Technical Program Manager
Subscribe through email: